Clinical Cancer Research Journal Issues Research Articles in Sept. 1, 2021 Edition
September 01, 2021
September 01, 2021
PHILADELPHIA, Pennsylvania, Sept. 1 -- Clinical Cancer Research, a journal from the American Association for Cancer Research that presents clinical and translational cancer research studies that bridge the laboratory and the clinic, published research articles, including the following topics, in its Sept. 1, 2021 edition:
CCR Drug Updates:
* FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic . . .
CCR Drug Updates:
* FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic . . .